Facebook
X
LinkedIn
ForwardHWCI Radiation Oncology Grand Rounds: Evolving Landscape of Theranostics
Theranostics is rapidly evolving from a relatively small number of established radiopharmaceutical therapies into a broader precision oncology platform encompassing new disease settings, molecular targets, radionuclides, combination strategies, and increasingly sophisticated approaches to patient selection and treatment personalization. This presentation will review the current clinical landscape and emerging pipeline while drawing on experience from a high-volume theranostics and early-phase clinical trials program to illustrate the infrastructure, multidisciplinary workforce, and operational models needed to successfully translate innovation into patient care. The discussion will also highlight opportunities for radiation oncologists to play an expanding role in the field's continued evolution.
Target Audience
Radiation Oncologists, Medical Oncologists, Oncology Surgeons, Physicists, Radiation Therapists and Radiologists
Learning Objectives
- Evaluate the evolving landscape of theranostics, including currently FDA-approved radiopharmaceutical therapies, emerging molecular targets, novel radionuclides, and key clinical trials shaping the future of cancer care.
- Apply theranostics principles within multidisciplinary oncology practice by identifying appropriate patients, optimizing treatment sequencing, incorporating molecular imaging, and collaborating across radiation oncology, nuclear medicine, medical oncology, and other specialties.
- Assess the infrastructure, workforce, and clinical research capabilities required to build and scale a successful theranostics program, including strategies to support early-phase, first-in-human, and first-in-world radiopharmaceutical trials.
Course Summary
- 1.00 ABS Accredited CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
Brandon R. Mancini, M.D., MBA, FACRO
Medical Director, BAMF Health
Clinical Associate Professor
Department of Radiology
Michigan State University College of Human Medicine
Brandon Mancini M.D., faculty for this educational activity, is and advisor for Lantheus and AstraZeneca and on the speakers bureau for Veracyte and Novartis. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for these individuals have been mitigated.
Michael Chuong, M.D., conference director of this educational activity, has received grant/research support from ViewRay, Novocure and StratPharma. He is a consultant for ViewRay and is on the board of directors for PCG. All of the relevant financial relationships listed for these individuals have been mitigated.
Rupesh Kotecha, M.D., content reviewer for this educational activity has received grant/research support from Medtronic Inc., Blue Earth Diagnostics, Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, Viewray Inc., Brainlab and Cantex. He is a consultant for Kazia Therapeutics, Elekta AB, Viewray Inc., Castle Biosciences, Novocure Inc. and Telix Pharmaceuticals. He is on the speaker’s bureau for Novocure. He has received travel services from Elekta AB and Novocure. He has done peer review with Institute for Medical Education, Brainlab and Viewray. All of the relevant financial relationships listed for these individuals have been mitigated.
Additional non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-621028, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Techs and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.
American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME- Complex General Surgery Oncology
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Available Credit
- 1.00 ABS Accredited CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
Required Hardware/Software
Continuing Education Credits
In order to confirm your participation in a live webinar and claim credit, please:
- Provide your full name and email address when you register for the webinar.
- Complete the post-conference evaluation and attestation form, which will be emailed to you after the activity.
Required Hardware/Software
 | Supported DevicesWhile the presentations may be viewable on systems that don't meet these criteria, it is recommended that your computer meet the minimum system requirements. Visit the Zoom Rooms page for system requirements and recommendations. Please plan to connect to the webinar transmission 15 minutes prior to the start time to test your connectivity. |
 | Technical SupportYou can test your connection to Zoom prior to the scheduled time by visiting Zoom Help Center. If you have technical difficulties accessing a webinar, please first consult our Zoom Rooms and troubleshooting tips. If your system meets these parameters, for technical assistance, call 888-799-9666. |